O'Rourke & Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

O'Rourke & Company’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Sell	1,605 -5,744	-78%	-$886K	0.44%	57
2025 Q4	$1.14M	Buy	7,349 +360	+5%	+$53.9K	0.44%	54
2025 Q3	$973K	Sell	6,989 -80	-1%	-$10.8K	0.41%	54
2025 Q2	$953K	Buy	7,069 +1,578	+29%	+$213K	0.44%	53
2025 Q1	$802K	Buy	5,491 +7	+0.1%	+$1.02K	0.4%	59
2024 Q4	$754K	Sell	5,484 -333	-6%	-$48.7K	0.37%	60
2024 Q3	$896K	Sell	5,817 -179	-3%	-$27.1K	0.45%	50
2024 Q2	$874K	Buy	5,996 +282	+5%	+$40.5K	0.49%	45
2024 Q1	$844K	Buy	5,714 +595	+12%	+$85.4K	0.49%	47
2023 Q4	$698K	Sell	5,119 -128	-2%	-$16.7K	0.45%	51
2023 Q3	$675K	Buy	5,247 +239	+5%	+$31.7K	0.49%	46
2023 Q2	$665K	Sell	5,008 -4	-0.1%	-$527	0.47%	50
2023 Q1	$649K	Sell	5,012 -574	-10%	-$75K	0.49%	51
2022 Q4	$759K	Buy	5,586 +21	+0.4%	+$2.78K	0.6%	45
2022 Q3	$674K	Buy	5,565 +265	+5%	+$34.1K	0.59%	44
2022 Q2	$680K	Sell	5,300 -7	-0.1%	-$918	0.58%	46
2022 Q1	$727K	Buy	5,307 +77	+1%	+$10.2K	0.5%	48
2021 Q4	$737K	Buy	+5,230	New	+$694K	0.49%	47

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

O'Rourke & Company's XLV Position: Q1 2026 in Review

O'Rourke & Company reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 78% in Q1 2026, selling an estimated $886K and leaving 1,605 shares worth $1.11M. The position accounts for 0.44% of the portfolio, ranked #57.

O'Rourke & Company first reported a position in XLV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.14M in Q4 2025. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

O'Rourke & Company held 1,605 shares of State Street Health Care Select Sector SPDR ETF worth $1.11M as of Q1 2026.
O'Rourke & Company sold 5,744 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $886K.
State Street Health Care Select Sector SPDR ETF made up 0.44% of O'Rourke & Company's portfolio in Q1 2026, its #57 holding.
O'Rourke & Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2021 and has held it in 18 quarters since.
O'Rourke & Company's State Street Health Care Select Sector SPDR ETF position peaked at $1.14M in Q4 2025.
1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on O'Rourke & Company's 13F filing for Q1 2026, filed 14 May 2026.